Anthropic Confirms It Operates a Wet Biology Lab for AI-Driven Physical Experiments

Anthropic has confirmed to TechCrunch that it is operating a wet biology lab in the San Francisco Bay Area, utilizing its AI models to conduct real-world physical experiments. The venture aligns with ambitious industry projections about biotechnology. Anthropic CEO Dario Amodei stated just last week his belief that artificial intelligence could cure most major diseases within the next five to ten years—a milestone that requires testing computational theories within laboratory environments. Speaking to Reuters, Anthropic's head of life sciences, Eric Kauderer-Abrams, explained that physical lab work remains the ultimate benchmark for biological research. He noted that the Bay Area facility functions similarly to standard biotech facilities, balancing internal research projects with outside partnerships. The disclosure follows Anthropic's quiet acquisition of stealth biotech startup Coefficient Bio in April. Anthropic declined to reveal specific experiments underway but stated that the primary objective is fundamental biology rather than commercial drug discovery. This distinction prevents friction with its major pharmaceutical clients and collaborators, including Novo Nordisk, with whom Anthropic recently announced a joint initiative. Alongside the lab's operations, Anthropic introduced a Life Sciences Verification Program to provide vetted researchers access to its top-tier models and published papers highlighting advances in bimolecular modeling and protein design. The scientific updates come amid broader safety discussions surrounding the company, following the resignation of researcher Jacob Coxon and previous comments from Anthropic's alignment lead placing the existential threat of AI to humanity at over 10%.